Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Estor is an Italian medical technology company specializing in the field of extracorporeal blood purification for critical care applications. Founded in 1986 and headquartered near Milan, the company is a leader in the treatment of severe sepsis and septic shock, notably through its long-term partnership with Toray Industries for the distribution and clinical development of Toraymyxin, a polymyxin B hemoperfusion column. Estor's portfolio also includes advanced technologies for extracorporeal CO2 removal (ECCO2R) and continuous renal replacement therapy (CRRT), designed to support patients with respiratory and renal failure. The company maintains a strong clinical focus, collaborating with intensive care units across Europe to provide evidence-based solutions for complex, life-threatening conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Estor.